Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSP3-CRM-Vac4All Malaria Vaccine in Young Children in Mali
NCT05776017Phase 2Unknown
- Sponsor
- Vac4All
- Start
- Mar 2023
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MSP3-CRM-Vac4All in Plasmodium falciparum malaria, sponsored by Vac4All. Status: unknown.
02
Drugs
MSP3-CRM-Vac4All
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT05776017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05776017.